The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citationMassberg, S., Schaerli, P., Knezevic-Maramica, I., Köllnberger, M., Tubo, N., Moseman, E. A., Huff, I. V., Junt, T., Wagers, A. J., Mazo, I. B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.047 · Cited by 696
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694 · cited 1×
“S1P treatment increases the survival of B cells and T cell”
BackgroundFinding a way out: lymphocyte egress from lymphoid organs
Schwab, S. R., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1545 · Cited by 605 · cited 1×
“and in controlling their egress into blood and lymp”
BackgroundKruppel-like factor 2 regulates thymocyte and T-cell migration
Carlson, C. M., Endrizzi, B. T., Wu, J., Ding, X., Weinreich, M. A., Walsh, E. R., Wani, M. A., Lingrel, J. B., Hogquist, K. A., & Jameson, S. C. (2006) · Nature · doi:10.1038/nature04882 · Cited by 593 · cited 1×
“Transcriptional regulation occurs through the transactivation of the gene encoding S1PR1 by Kruppel-like factor 2 ( KLF2 ), which is a transcription factor containing a zinc-finger domai”
BackgroundFollicular shuttling of marginal zone B cells facilitates antigen transport
Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W., & Cyster, J. G. (2008) · Nature Immunology · doi:10.1038/ni1542 · Cited by 543 · cited 1×
“Through this S1P-driven shuttling mechanism, specialized B cells can pick-up antigens from the blood that filters through the marginal zone, deliver them to follicular DCs and then return back to the marginal zon”
BackgroundThe immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors
Gräler, M. H., & Goetzl, E. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0910fje · Cited by 539 · cited 1×
“with potent effects, including S1PR agonism and the downregulation of S1PR expressio”
BackgroundVascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
Venkataraman, K., Lee, Y.-M., Michaud, J., Thangada, S., Ai, Y., Bonkovsky, H. L., Parikh, N. S., Habrukowich, C., & Hla, T. (2008) · Circulation Research · doi:10.1161/circresaha.107.165845 · Cited by 482 · cited 1×
“S1P in the lymph is not derived from erythrocytes or other haematopoietic cells but comes from a radio-resistant source, probably the endotheliu”
BackgroundHla, T., & Maciag, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38849-0 · Cited by 476
Imatinib mesylate blocks a non‐Smad TGF‐β pathway and reduces renal fibrogenesis in vivo
Wang, S., Wilkes, M. C., Leof, E. B., & Hirschberg, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-2370com · Cited by 463
Structural and functional characteristics of S1P receptors
Sanchez, T., & Hla, T. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20127 · Cited by 456 · cited 1×
“Here, we focus on its cell-extrinsic function in the immune system, where it acts as a ligand for a family of five G-protein-coupled receptors (GPCRs), known as S1P receptor 1 ( S1PR1 )– S1PR5 (Ref”
BackgroundExpression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration
Allende, M. L., Dreier, J. L., Mandala, S., & Proia, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314291200 · Cited by 452 · cited 1×
“For example, S1PR1 is decisive for B- and T-cell egress from lymph nodes and for the exit of mature thymocytes — both conventional T cells and natural killer T (NKT) cells — from the thymu”
BackgroundSelf-citationNatural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Walzer, T., Chiossone, L., Chaix, J., Calver, A., Carozzo, C., Garrigue-Antar, L., Jacques, Y., Baratin, M., Tomasello, E., & Vivier, E. (2007) · Nature Immunology · doi:10.1038/ni1523 · Cited by 431 · cited 1×
“S1PR5 was recently shown to be expressed by dendritic cells (DCs) and natural killer (NK) cell”
BackgroundPham, T. H. M., Okada, T., Matloubian, M., Lo, C. G., & Cyster, J. G. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.017 · Cited by 427
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone
Cinamon, G., Matloubian, M., Lesneski, M. J., Xu, Y., Low, C., Lu, T., Proia, R. L., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1083 · Cited by 418 · cited 1×
“An example is the localization and movement of marginal-zone B cells in the spleen, which depend on their expression of S1PR1 (Ref”
BackgroundSelf-citationRole of ABCC1 in export of sphingosine-1-phosphate from mast cells
Mitra, P., Oskeritzian, C. A., Payne, S. G., Beaven, M. A., Milstien, S., & Spiegel, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603734103 · Cited by 407 · cited 1×
“The transport of S1P across membranes can be mediated by the ATP-binding cassette (ABC) family of transporters”
BackgroundSanna, M. G., Wang, S.-K., Gonzalez-Cabrera, P. J., Don, A., Marsolais, D., Matheu, M. P., Wei, S. H., Parker, I., Jo, E., Cheng, W.-C., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio804 · Cited by 406
Oo, M. L., Thangada, S., Wu, M.-T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C.-Y., & Hla, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610318200 · Cited by 405
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
Allende, M. L., Yamashita, T., & Proia, R. L. (2003) · Blood · doi:10.1182/blood-2003-02-0460 · Cited by 380 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationSanchez, T., Estrada-Hernandez, T., Paik, J.-H., Wu, M.-T., Venkataraman, K., Brinkmann, V., Claffey, K., & Hla, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306896200 · Cited by 374 · cited 1×
“and in strengthening endothelial-cell–endothelial-cell junctional contact”
Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor
Hong Choi, O., Kim, J.-H., & Kinet, J.-P. (1996) · Nature · doi:10.1038/380634a0 · Cited by 371
Gude, D. R., Alvarez, S. E., Paugh, S. W., Mitra, P., Yu, J., Griffiths, R., Barbour, S. E., Milstien, S., & Spiegel, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107169 · Cited by 364
Erythrocytes store and release sphingosine 1‐phosphate in blood
Hänel, P., Andréani, P., & Gräler, M. H. (2007) · The FASEB Journal · doi:10.1096/fj.06-7433com · Cited by 361 · cited 1×
“However, erythrocytes that have been isolated from plasma or serum do not secrete S1P, which indicates that a factor(s) present in plasma might be required for the constitutive secretion of S1P from these cell”
BackgroundJiang, L. I., Collins, J., Davis, R., Lin, K.-M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R. A., Ross, E. M., Taussig, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609695200 · Cited by 358 · cited 1×
“S1PR1 and S1PR2 have been shown to be expressed by different populations or genetic origins of macrophages and monocyte”
BackgroundOkamoto, H., Takuwa, N., Yokomizo, T., Sugimoto, N., Sakurada, S., Shigematsu, H., & Takuwa, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9247-9261.2000 · Cited by 329 · cited 1×
“In other cell types, the inhibition of migration by S1PR2 was shown to involve activation of the RAC1-GTPase-activating protein and consequent inhibition of RAC1 activit”
BackgroundJolly, P. S., Bektas, M., Olivera, A., Gonzalez-Espinosa, C., Proia, R. L., Rivera, J., Milstien, S., & Spiegel, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030680 · Cited by 319
Self-citationLo, C. G., Xu, Y., Proia, R. L., & Cyster, J. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041509 · Cited by 319
Self-citationAmmit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0742fje · Cited by 313 · cited 1×
“S1P levels are also increased in allergen-challenged asthmatics and in the joints of patients with rheumatoid arthriti”
BackgroundDendritic cell PAR1–S1P3 signalling couples coagulation and inflammation
Niessen, F., Schaffner, F., Furlan-Freguia, C., Pawlinski, R., Bhattacharjee, G., Chun, J., Derian, C. K., Andrade-Gordon, P., Rosen, H., & Ruf, W. (2008) · Nature · doi:10.1038/nature06663 · Cited by 280 · cited 1×
“Recently, another role for S1PRs in DC function was uncovered in a model of severe sepsis using an LPS challeng”
BackgroundWei, S. H., Rosen, H., Matheu, M. P., Sanna, M. G., Wang, S.-K., Jo, E., Wong, C.-H., Parker, I., & Cahalan, M. D. (2005) · Nature Immunology · doi:10.1038/ni1269 · Cited by 277 · cited 1×
“The induction of a block in lymphocyte egress by S1PR1 agonists, such as FTY720, and the reported failure of S1PR1 antagonism to induce an egress block are consistent with this mode”
ResultSugimoto, N., Takuwa, N., Okamoto, H., Sakurada, S., & Takuwa, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1534-1545.2003 · Cited by 264
Idzko, M., Hammad, H., Nimwegen, M. V., Kool, M., Müller, T., Soullié, T., Willart, M. A. M., Hijdra, D., Hoogsteden, H. C., & Lambrecht, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28295 · Cited by 258 · cited 1×
“DCs from mouse lungs or those derived in vitro from bone marrow express all of the S1PR subtype”
BackgroundSphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages
Hughes, J. E., Srinivasan, S., Lynch, K. R., Proia, R. L., Ferdek, P., & Hedrick, C. C. (2008) · Circulation Research · doi:10.1161/circresaha.107.170779 · Cited by 252 · cited 1×
“S1PR1 and S1PR2 have been shown to be expressed by different populations or genetic origins of macrophages and monocyte”
BackgroundSelf-citationLedgerwood, L. G., Lal, G., Zhang, N., Garin, A., Esses, S. J., Ginhoux, F., Merad, M., Peche, H., Lira, S. A., Ding, Y., et al. (2008) · Nature Immunology · doi:10.1038/ni1534 · Cited by 249
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage
Kaneider, N. C., Leger, A. J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L., & Kuliopulos, A. (2007) · Nature Immunology · doi:10.1038/ni1525 · Cited by 233 · cited 1×
“Coagulation has a pro-inflammatory role in sepsis, whereas PAR1 has been shown to have both protective and harmful effects in terms of vascular integrity and lethality depending on the stage of sepsi”
BackgroundPlasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism
Kabashima, K., Haynes, N. M., Xu, Y., Nutt, S. L., Allende, M. L., Proia, R. L., & Cyster, J. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061289 · Cited by 220 · cited 1×
“Similarly, during an antibody response, S1PR1 on IgG-secreting plasma cells is required for the cells to move from the spleen into the blood and, ultimately, to the bone marro”
BackgroundSelf-citationTh17 Cells and Autoimmune Encephalomyelitis (EAE/MS)
Aranami, T., & Yamamura, T. (2008) · Allergology International · doi:10.2332/allergolint.r-07-159 · Cited by 218 · cited 1×
“Although multiple sclerosis was thought to be a T H 1-cell-associated disease, it is now known that T H 17 cells are essential for the development of disease in mic”
BackgroundNofer, J.-R., Bot, M., Brodde, M., Taylor, P. J., Salm, P., Brinkmann, V., van Berkel, T., Assmann, G., & Biessen, E. A. L. (2007) · Circulation · doi:10.1161/circulationaha.106.641407 · Cited by 217
Sebzda, E., Zou, Z., Lee, J. S., Wang, T., & Kahn, M. L. (2008) · Nature Immunology · doi:10.1038/ni1565 · Cited by 213 · cited 1×
“Transcriptional regulation occurs through the transactivation of the gene encoding S1PR1 by Kruppel-like factor 2 ( KLF2 ), which is a transcription factor containing a zinc-finger domai”
BackgroundBai, A., Hu, H., Yeung, M., & Chen, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7632 · Cited by 212
Olivera, A., Mizugishi, K., Tikhonova, A., Ciaccia, L., Odom, S., Proia, R. L., & Rivera, J. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.008 · Cited by 206
Self-citationIdzko, M., Panther, E., Corinti, S., Morelli, A., Ferrari, D., Herouy, Y., Dichmann, S., Mockenhaupt, M., Gebicke-Haerter, P., Di Virgilio, F., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0625fje · Cited by 183
Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate
Deutschman, D. H., Carstens, J. S., Klepper, R. L., Smith, W. S., Page, M. T., Young, T. R., Gleason, L. A., Nakajima, N., & Sabbadini, R. A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00118-2 · Cited by 181
Weigert, A., Johann, A. M., von Knethen, A., Schmidt, H., Geisslinger, G., & Brüne, B. (2006) · Blood · doi:10.1182/blood-2006-04-014852 · Cited by 173 · cited 1×
“S1P that is generated by apoptotic tumour cells through SPHK2 (Ref”
BackgroundPrieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E., & Baumruker, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.1 · Cited by 171
Tumor Cell Apoptosis Polarizes Macrophages—Role of Sphingosine-1-Phosphate
Weigert, A., Tzieply, N., von Knethen, A., Johann, A. M., Schmidt, H., Geisslinger, G., & Brüne, B. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1096 · Cited by 171 · cited 1×
“Interestingly, the polarization towards M2-type macrophages that is associated with tumours, which correlates with poor survival prognosis, is mediated in part by S1P production by tumour cells undergoing apoptosi”
BackgroundKitano, M., Hla, T., Sekiguchi, M., Kawahito, Y., Yoshimura, R., Miyazawa, K., Iwasaki, T., & Sano, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21668 · Cited by 165 · cited 1×
“S1P levels are also increased in allergen-challenged asthmatics and in the joints of patients with rheumatoid arthriti”
BackgroundTipping the gatekeeper: S1P regulation of endothelial barrier function
Rosen, H., Sanna, M., Cahalan, S. M., & Gonzalez‐Cabrera, P. J. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.007 · Cited by 159 · cited 1×
“S1PR signalling controlling immune-cell egress from lymphoid organs might be immune-cell or endothelial-cell centre”
BackgroundSphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner
Kobayashi, N., Nishi, T., Hirata, T., Kihara, A., Sano, T., Igarashi, Y., & Yamaguchi, A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500468-jlr200 · Cited by 159 · cited 1×
“The transport of S1P across membranes can be mediated by the ATP-binding cassette (ABC) family of transporters”
BackgroundFoss, F. W., Snyder, A. H., Davis, M. D., Rouse, M., Okusa, M. D., Lynch, K. R., & Macdonald, T. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.060 · Cited by 158 · cited 1×
“The induction of a block in lymphocyte egress by S1PR1 agonists, such as FTY720, and the reported failure of S1PR1 antagonism to induce an egress block are consistent with this mode”
ResultFoster, C. A., Mechtcheriakova, D., Storch, M. K., Balatoni, B., Howard, L. M., Bornancin, F., Wlachos, A., Sobanov, J., Kinnunen, A., & Baumruker, T. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00182.x · Cited by 156 · cited 1×
“FTY720 has also been shown to reverse 'leakiness' of the blood–brain barrier and decrease demyelination in animal models of this diseas”
BackgroundWang, W., Gräler, M. H., & Goetzl, E. J. (2005) · The FASEB Journal · doi:10.1096/fj.05-3730fje · Cited by 147 · cited 1×
“By contrast, signalling through S1PR4 suppresses production of both cytokines equally while increasing the production of IL-10 (Ref”
BackgroundBoujaoude, L. C., Bradshaw-Wilder, C., Mao, C., Cohn, J., Öğretmen, B., Hannun, Y. A., & Obeid, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105442200 · Cited by 140
Maeda, Y., Matsuyuki, H., Shimano, K., Kataoka, H., Sugahara, K., & Chiba, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3437 · Cited by 139
Olivera, A., Urtz, N., Mizugishi, K., Yamashita, Y., Gilfillan, A. M., Furumoto, Y., Gu, H., Proia, R. L., Baumruker, T., & Rivera, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508931200 · Cited by 138
Self-citationGenetic Background and the Dilemma of Translating Mouse Studies to Humans
Rivera, J., & Tessarollo, L. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.008 · Cited by 137
Self-citationSphingolipids and the Balancing of Immune Cell Function: Lessons from the Mast Cell
Olivera, A., & Rivera, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1153 · Cited by 136
Self-citationMariño, E., Batten, M., Groom, J. R., Walters, S. N., Liuwantara, D., Mackay, F., & Grey, S. T. (2007) · Diabetes · doi:10.2337/db07-0589 · Cited by 131 · cited 1×
“Although this effect is probably related to the inhibition of CD4 + T-cell egress into the pancreas, it might also reflect the downregulation of the S1P-hyperresponsive phenotype of marginal-zone B cells that is found in this disease mode”
BackgroundIntracellular Generation of Sphingosine 1-Phosphate in Human Lung Endothelial Cells
Zhao, Y., Kalari, S. K., Usatyuk, P. V., Gorshkova, I. A., He, D., Watkins, T., Brindley, D. N., Sun, C., Bittman, R., Garcia, J. G. N., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701279200 · Cited by 128 · cited 1×
“S1P is synthesized in most cells, but then is irreversibly degraded by intracellular S1P lyase or dephosphorylated by S1P phosphatase”
BackgroundSphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses
Mechtcheriakova, D., Wlachos, A., Sobanov, J., Kopp, T., Reuschel, R., Bornancin, F., Cai, R. L., Zemann, B., Urtz, N., Stingl, G., et al. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.004 · Cited by 125 · cited 1×
“S1P is synthesized in most cells, but then is irreversibly degraded by intracellular S1P lyase or dephosphorylated by S1P phosphatase”
BackgroundMüller, H., Hofer, S., Kaneider, N. C., Neuwirt, H., Mosheimer, B. A., Mayer, G. J., Konwalinka, G., Heufler, C., & Tiefenthaler, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425556 · Cited by 123
Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate
Liao, J., Huang, M., & Goetzl, E. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5425 · Cited by 123
Science review: role of coagulation protease cascades in sepsis.
Riewald, M., & Ruf, W. (2003) · Critical Care · doi:10.1186/cc1825 · Cited by 122 · cited 1×
“During sepsis, the innate immune system is systemically hyperstimulated, leading to the activation of the blood coagulation cascade, which produces microvascular thrombosis and disseminated intravascular coagulatio”
BackgroundDistinct roles of sphingosine kinases 1 and 2 in human mast-cell functions
Oskeritzian, C. A., Alvarez, S. E., Hait, N. C., Price, M. M., Milstien, S., & Spiegel, S. (2008) · Blood · doi:10.1182/blood-2007-09-115451 · Cited by 118 · cited 1×
“Although numerous studies clearly agree on the crucial role of SPHKs and S1P generation in mast-cell responses, the dominant effect of SPHK2 that was observed in the mouse genetic-deletion models contrasts with the finding that SPHK1 has a dominant role in the generation of active S1P in studies of human mast cell”
ResultThe Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo
Lan, Y. Y., Creus, A. D., Colvin, B. L., Abe, M., Brinkmann, V., Coates, P. T., & Thomson, A. W. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01085.x · Cited by 117
Halin, C., Scimone, M. L., Bonasio, R., Gauguet, J.-M., Mempel, T. R., Quackenbush, E. J., Proia, R. L., MANDALA, S. M., & von Andrian, U. H. (2005) · Blood · doi:10.1182/blood-2004-09-3687 · Cited by 112
Self-citationDorsam, G. P., Gräler, M. H., Seroogy, C. M., Kong, Y., Voice, J. K., & Goetzl, E. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3500 · Cited by 103
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate
Roviezzo, F., Del Galdo, F., Abbate, G., Bucci, M., D'Agostino, B., Antunes, E., De Dominicis, G., Parente, L., Rossi, F., Cirino, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401439101 · Cited by 100
Gohda, M., Kunisawa, J., Miura, F., Kagiyama, Y., Kurashima, Y., Higuchi, M., Ishikawa, I., Ogahara, I., & Kiyono, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5335 · Cited by 98
Song, J., Matsuda, C., Kai, Y., Nishida, T., Nakajima, K., Mizushima, T., Kinoshita, M., Yasue, T., Sawa, Y., & Ito, T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119172 · Cited by 98 · cited 1×
“In CD4 + T cells, signalling through S1PR1 either preferentially inhibits IFNγ production, when compared with IL-4 productio”
BackgroundPlasma sphingosine 1-phosphate metabolism and analysis
Yatomi, Y. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.10.006 · Cited by 97 · cited 1×
“Free S1P or S1P bound to serum albumin is more susceptible to degradation than S1P bound to lipoproteins, such as high-density lipoprotein (HDL”
Backgroundマスト細胞からのスフィンゴシン‐1‐りん酸の運び出しに果たすABCC1の役割
Mitra, P., Carole, A. O., Shawn, G. P., Michael, A. B., Milstien, S., & Sarah, S. (2006) · Cited by 95
Singer, I. I., Tian, M., Wickham, L. A., Lin, J. J., Matheravidathu, S. S., Forrest, M. J., MANDALA, S. M., & Quackenbush, E. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7151 · Cited by 92
Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation
Jin, Y., Knudsen, E., Wang, L., Bryceson, Y. T., Damaj, B. B., Gessani, S., & Maghazachi, A. A. (2003) · Blood · doi:10.1182/blood-2002-09-2962 · Cited by 91 · cited 1×
“, inhibits both the homeostatic proliferation and T-cell receptor (TCR)-induced proliferation of CD4 + T cell”
BackgroundActivation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate
Fueller, M., Wang, D. A., Tigyi, G., & Siess, W. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00117-1 · Cited by 89 · cited 1×
“S1PR1 and S1PR2 have been shown to be expressed by different populations or genetic origins of macrophages and monocyte”
BackgroundGonzalez‐Cabrera, P. J., Hla, T., & Rosen, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610581200 · Cited by 85 · cited 1×
“Interestingly, the synthetic receptor agonist FTY720 is highly active at inducing the internalization, ubiquitylation and subsequent degradation of S1PR1, which indicates that its inhibitory action on immune-cell trafficking might be through receptor downmodulatio”
BackgroundS1P 1 receptor expression regulates emergence of NKT cells in peripheral tissues
Allende, M. L., Zhou, D., Kalkofen, D. N., Benhamed, S., Tuymetova, G., Borowski, C., Bendelac, A. S., & Proia, R. L. (2007) · The FASEB Journal · doi:10.1096/fj.07-9087com · Cited by 80 · cited 1×
“For example, S1PR1 is decisive for B- and T-cell egress from lymph nodes and for the exit of mature thymocytes — both conventional T cells and natural killer T (NKT) cells — from the thymu”
BackgroundSelf-citationPeest, U., Sensken, S.-C., Andréani, P., Hänel, P., Veldhoven, P. P. V., & Gräler, M. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21665 · Cited by 74 · cited 1×
“S1P is synthesized in most cells, but then is irreversibly degraded by intracellular S1P lyase or dephosphorylated by S1P phosphatase”
BackgroundCutting Edge: Genetic Variation Influences FcεRI-Induced Mast Cell Activation and Allergic Responses
Yamashita, Y., Charles, N., Furumoto, Y., Odom, S., Yamashita, T., Gilfillan, A. M., Constant, S. L., Bower, M. A., Ryan, J. J., & Rivera, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.740 · Cited by 73
Self-citationYopp, A. C., Fu, S., Honig, S., Randolph, G. J., Ding, Y., Krieger, N. R., & Bromberg, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.855 · Cited by 73
Buckland, J. (2002) · Nature reviews. Immunology · doi:10.1038/nri963 · Cited by 71
Maki, T., Gottschalk, R., Ogawa, N., & Monaco, A. P. (2005) · Transplantation · doi:10.1097/01.tp.0000161220.87548.ee · Cited by 68 · cited 1×
“In the non-obese diabetic (NOD) mouse model of autoimmune type 1 diabetes mellitus, which is a T H 1-cell-associated disease, treatment with FTY720 was either beneficial or cured spontaneous diabete”
BackgroundAlfonso, C., McHeyzer‐Williams, M. G., & Rosen, H. (2005) · European Journal of Immunology · doi:10.1002/eji.200535127 · Cited by 65 · cited 1×
“3 ) and is tightly linked to S1PR1 expression and activit”
BackgroundKurashima, Y., Kunisawa, J., Higuchi, M., Gohda, M., Ishikawa, I., Satoh‐Takayama, N., Shimizu, M., & Kiyono, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1577 · Cited by 64
Sphingosine 1‐Phosphate: A Ligand for the EDG‐1 Family of G‐Protein‐Coupled Receptors
Spiegel, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06537.x · Cited by 64 · cited 1×
“Once it was realized that the ligand for this orphan receptor was S1P (reviewed in Ref”
BackgroundGräler, M. H., Huang, M., Watson, S. R., & Goetzl, E. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1997 · Cited by 63
Src family kinases and lipid mediators in control of allergic inflammation
Rivera, J., & Olivera, A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00505.x · Cited by 63 · cited 1×
“This sphingolipid metabolite has both cell-intrinsic and cell-extrinsic activity, affecting cell homeostasis and functio”
BackgroundSelf-citationSphingosine-1 Phosphate Signaling Regulates Positioning of Dendritic Cells within the Spleen
Czeloth, N., Schippers, A., Wagner, N., Müller, W., Küster, B., Bernhardt, G., & Förster, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5855 · Cited by 61
Novel Therapies for Microvascular Permeability in Sepsis
Jacobson, J., & Garcia, J. G. N. (2007) · Current Drug Targets · doi:10.2174/138945007780362719 · Cited by 56 · cited 1×
“S1P–S1PR and disease Maintaining S1P homeostasis is important for preventing unwanted immune responses and for maintaining appropriate vascular barrier integrity, disruption of which increases permeability to fluid and solute and is the main pathophysiological mechanism of many inflammatory disease processes, such as…”
BackgroundDuenas, A. I., Aceves, M., Fernández‐Pisonero, I., Gómez, C., Orduña, A., Crespo, M. S., & García‐Rodríguez, C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn087 · Cited by 54
Huang, M., Watson, S. R., Liao, J., & Goetzl, E. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6806 · Cited by 52
Role of Sphingosine 1-Phosphate in the Pathogenesis of Sjogren’s Syndrome
Sekiguchi, M., Iwasaki, T., Kitano, M., Kuno, H., Hashimoto, N., Kawahito, Y., Azuma, M., Hla, T., & Sano, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1921 · Cited by 50
Matsuyuki, H., Maeda, Y., Yano, K., Sugahara, K., Chiba, K., Kohno, T., & Igarashi, Y. (2006) · PubMed · Cited by 43
Srinivasan, S. R., Bolick, D. T., Lukashev, D. E., Lappas, C. M., Sitkovsky, M. V., Lynch, K. R., & Hedrick, C. C. (2007) · Diabetes · doi:10.2337/db07-0855 · Cited by 41 · cited 1×
“In the non-obese diabetic (NOD) mouse model of autoimmune type 1 diabetes mellitus, which is a T H 1-cell-associated disease, treatment with FTY720 was either beneficial or cured spontaneous diabete”
BackgroundWang, W., Huang, M., & Goetzl, E. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4885 · Cited by 39
The immunomodulator FTY720 is phosphorylated and released from platelets
Anada, Y., Igarashi, Y., & Kihara, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.053 · Cited by 36 · cited 1×
“In addition to the ABC-transporter-mediated S1P export, a calcium-dependent and ATP-independent transport mechanism has also been described in platelets, but its components have not yet been identifie”
BackgroundKunisawa, J., Gohda, M., Kurashima, Y., Ishikawa, I., Higuchi, M., & Kiyono, H. (2008) · Blood · doi:10.1182/blood-2007-10-120071 · Cited by 31
Yokoo, E. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh081 · Cited by 21
Frontiers in Immunosuppression
Kahan, B. D. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.12.007 · Cited by 7 · cited 1×
“3 ), is an appealing strategy to block T-cell-mediated rejection of organ transplantation, a Phase III clinical trial in kidney-transplant recipients revealed serious side effects, such as decreased renal function, when FTY720 was used in combination with cyclosporin (reviewed in Ref”
Background
Cited by
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
“important role in innate immune responses (120)”
BackgroundRevisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
Cell Biology of Cnidarian-Dinoflagellate Symbiosis
Davy, S. K., Allemand, D., & Weis, V. M. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05014-11 · Cited by 1,092
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“S1P is a biologically active phospholipid generated from ceramide which controls proliferation of several cell types and leukocyte trafficking from lymphoid tissues into circulation (Rivera et al., 2008).”
Background
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.